Official OCEMS site ↗
← Medication guides

Field medications · Adult & pediatric guidance · ALS

Midazolam (Versed)

Seizure control and indication-specific sedation, with distinct adult and pediatric limits.

OCEMS source summary · Updated 2026-09-16

Check before giving

  • Be ready to assist ventilation and protect the airway if respiratory depression occurs.
  • Adult seizure: contact base if activity continues for 5 minutes after the first IM dose or second IV/IN/IO dose (10 mg total by any route).

Use in OCEMS

  • Used in active/recurrent seizures and specific pacing, airway, and behavioral-emergency pathways.
  • A seizure dose does not authorize all sedation uses. Select the condition order and its blood-pressure, repeat-dose, and base-contact rules.

Adult / adolescent

Indication / routeDose & limits
Active seizure — preferred10 mg IM once, before attempting new IV/IO access.
Seizure — alternative5 mg IV/IN/IO if IM cannot be delivered or IV/IO already exists; may repeat once after about 3 minutes for ongoing/recurrent activity.
Pacing distressWhen systolic BP is above 90: up to 5 mg IV slowly titrated. If IV cannot be obtained, 5 mg IN divided between nostrils; may repeat once after about 3 minutes.
Toxic delirium interfering with loadingSO-M-030: 5 mg IV, repeat once in 5 minutes if no improvement; OR 10 mg IM/IN once. For patients older than 65, consider 5 mg IM/IN, repeat once in 5 minutes if needed.
Specified airway sedation — I-15 / SO-M-0805 mg IV/IO/IM once for the listed jaw-tone/airway-placement or pre-existing tube-tolerance indication when systolic BP is above 90. Follow the complete airway order.

Pediatric

  • Seizure SO-P-075: 0.2 mg/kg IM once, maximum 10 mg. Alternative when IM cannot be given or IV/IO is already present: 0.1 mg/kg IN/IV/IO, maximum 5 mg; repeat once after 3 minutes for continued/recurrent seizures.
  • Base contact is required for all pediatric seizure patients, whether transported or not; pediatric-capable base preferred.
  • SO-P-070 toxic delirium interfering with loading: contact base (pediatric-capable preferred) for a possible 0.2 mg/kg IM/IN one-time order, maximum 10 mg. This is not an independent pediatric standing-order sedation dose.
  • SO-P-120 pre-existing, correctly positioned ETT that is poorly tolerated: with systolic BP above 80, consider 0.1 mg/kg IV/IO/IM once, maximum 5 mg. Base contact is required. Reassess BP; if it falls below 80, give 20 mL/kg saline, maximum 250 mL, and reassess. Monitor oxygenation/ventilation and do not extubate after sedation under this pathway.
  • I-20 marks pediatric cardioversion sedation as base-order treatment; use that specific order rather than another indication’s regimen.

Pediatric weight table — Ongoing seizure — preferred IM route

  • Source: SO-P-075. Dose rule: 0.2 mg/kg; route: IM once.
  • 0.2 mg/kg IM once; maximum 10 mg. The IM first-line regimen is distinct from the lower alternate-route dose.
  • Base contact is required for every pediatric seizure patient, including non-transported patients. Monitor ventilation and prepare BVM support.
  • Calculated examples for the exact weights shown, using the named standing-order/procedure formula. Do not round the patient’s weight to the nearest row. For another weight, calculate from the stated formula and apply the limits. These are not the rounded I-20 weight-band volumes.
  • Volumes are mathematical examples rounded to at most three decimal places. Verify the vial concentration, dose, and measurable syringe volume before administration; follow agency preparation/rounding practice.
Exact weightDose — IM onceVolume at 5 mg/mL
3 kg0.6 mg0.12 mL
4 kg0.8 mg0.16 mL
5 kg1 mg0.2 mL
6 kg1.2 mg0.24 mL
8 kg1.6 mg0.32 mL
10 kg2 mg0.4 mL
12 kg2.4 mg0.48 mL
15 kg3 mg0.6 mL
20 kg4 mg0.8 mL
25 kg5 mg1 mL
30 kg6 mg1.2 mL
35 kg7 mg1.4 mL
40 kg8 mg1.6 mL
45 kg9 mg1.8 mL
50 kg10 mg2 mL
60 kg10 mg2 mL

Pediatric weight table — Ongoing seizure — alternate IN/IV/IO

  • Source: SO-P-075. Dose rule: 0.1 mg/kg; route: IN/IV/IO.
  • When IM cannot be delivered or IV/IO is already present: 0.1 mg/kg IN/IV/IO; maximum 5 mg per dose. May repeat once after 3 minutes for continued or recurrent seizure.
  • Base contact is required for all pediatric seizure patients. This is not the 0.2 mg/kg IM first-line dose.
  • Calculated examples for the exact weights shown, using the named standing-order/procedure formula. Do not round the patient’s weight to the nearest row. For another weight, calculate from the stated formula and apply the limits. These are not the rounded I-20 weight-band volumes.
  • Volumes are mathematical examples rounded to at most three decimal places. Verify the vial concentration, dose, and measurable syringe volume before administration; follow agency preparation/rounding practice.
Exact weightDose — IN/IV/IOVolume at 5 mg/mL
3 kg0.3 mg0.06 mL
4 kg0.4 mg0.08 mL
5 kg0.5 mg0.1 mL
6 kg0.6 mg0.12 mL
8 kg0.8 mg0.16 mL
10 kg1 mg0.2 mL
12 kg1.2 mg0.24 mL
15 kg1.5 mg0.3 mL
20 kg2 mg0.4 mL
25 kg2.5 mg0.5 mL
30 kg3 mg0.6 mL
35 kg3.5 mg0.7 mL
40 kg4 mg0.8 mL
45 kg4.5 mg0.9 mL
50 kg5 mg1 mL
60 kg5 mg1 mL

Pediatric weight table — Toxic delirium interfering with loading

  • Source: SO-P-070. Dose rule: 0.2 mg/kg; route: IM/IN once.
  • Possible base-ordered dose: 0.2 mg/kg IM/IN once, maximum 10 mg, for the specific toxic-delirium/loading indication.
  • Base contact and direction are required; a calculated dose does not create independent standing-order sedation authority.
  • Calculated examples for the exact weights shown, using the named standing-order/procedure formula. Do not round the patient’s weight to the nearest row. For another weight, calculate from the stated formula and apply the limits. These are not the rounded I-20 weight-band volumes.
  • Volumes are mathematical examples rounded to at most three decimal places. Verify the vial concentration, dose, and measurable syringe volume before administration; follow agency preparation/rounding practice.
Exact weightDose — IM/IN onceVolume at 5 mg/mL
3 kg0.6 mg0.12 mL
4 kg0.8 mg0.16 mL
5 kg1 mg0.2 mL
6 kg1.2 mg0.24 mL
8 kg1.6 mg0.32 mL
10 kg2 mg0.4 mL
12 kg2.4 mg0.48 mL
15 kg3 mg0.6 mL
20 kg4 mg0.8 mL
25 kg5 mg1 mL
30 kg6 mg1.2 mL
35 kg7 mg1.4 mL
40 kg8 mg1.6 mL
45 kg9 mg1.8 mL
50 kg10 mg2 mL
60 kg10 mg2 mL

Pediatric weight table — Poorly tolerated pre-existing ETT

  • Source: SO-P-120. Dose rule: 0.1 mg/kg; route: IV/IO/IM once.
  • For a correctly positioned, pre-existing ETT that is poorly tolerated and systolic BP above 80: 0.1 mg/kg IV/IO/IM once; maximum 5 mg.
  • Base contact is required. Monitor oxygenation, ventilation, and BP; follow SO-P-120 for hypotension and do not extubate after sedation under this pathway.
  • Calculated examples for the exact weights shown, using the named standing-order/procedure formula. Do not round the patient’s weight to the nearest row. For another weight, calculate from the stated formula and apply the limits. These are not the rounded I-20 weight-band volumes.
  • Volumes are mathematical examples rounded to at most three decimal places. Verify the vial concentration, dose, and measurable syringe volume before administration; follow agency preparation/rounding practice.
Exact weightDose — IV/IO/IM onceVolume at 5 mg/mL
3 kg0.3 mg0.06 mL
4 kg0.4 mg0.08 mL
5 kg0.5 mg0.1 mL
6 kg0.6 mg0.12 mL
8 kg0.8 mg0.16 mL
10 kg1 mg0.2 mL
12 kg1.2 mg0.24 mL
15 kg1.5 mg0.3 mL
20 kg2 mg0.4 mL
25 kg2.5 mg0.5 mL
30 kg3 mg0.6 mL
35 kg3.5 mg0.7 mL
40 kg4 mg0.8 mL
45 kg4.5 mg0.9 mL
50 kg5 mg1 mL
60 kg5 mg1 mL

Pediatric weight bands — cardioversion sedation

  • I-20 pages 1–10: base hospital order required for cardioversion sedation; the chart lists IN/IV/IM and 5 mg/mL. Confirm the specific order and timing.
  • Published band doses below are distinct from seizure and toxic-delirium regimens. Do not extrapolate outside the bands.
I-20 weight bandBase-ordered doseConcentration
3–5 kg0.4 mg5 mg/mL
6–7 kg0.6 mg5 mg/mL
8–9 kg0.8 mg5 mg/mL
10–11 kg1 mg5 mg/mL
12–14 kg1.2 mg5 mg/mL
15–18 kg1.5 mg5 mg/mL
19–23 kg2 mg5 mg/mL
24–29 kg2.5 mg5 mg/mL
30–36 kg3.5 mg5 mg/mL
37–49 kg4.5 mg5 mg/mL

Preparation & reassessment

  • Stock is 5 mg/mL; verify route, dose, indication, previous doses, and timing.
  • Monitor oxygenation and ventilation. Seizure orders direct BVM assistance when ETCO₂ is 50 mmHg or more.
  • I-15 and the full behavioral order differ in some repeat-dose details; this page uses the indication-specific SO-M-030 wording. For airway sedation, open the linked SO-M-080 / SO-P-120 rather than reusing another row.